BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  CEL-SCI Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial

  March 3, 2008

   · 

  2 min read
• Genetown

  Cyberkinetics Neurotechnology Systems, Inc.’ Andara(TM) OFS(TM) Therapy Featured in Presentations at the AANS/CNS Meeting

  March 3, 2008

   · 

  1 min read
• Business

  Neurobiological Technologies, Inc. and Buck Institute for Age Research Partner to Develop Novel Treatment for Alzheimer’s Disease

  March 3, 2008

   · 

  4 min read
• Business

  ZIOPHARM Oncology, Inc. Appoints Steven Bloom as Vice President, Business Development and Barry Jones, Ph.D., as Senior Vice President, Preclinical Operations

  March 3, 2008

   · 

  1 min read
• Drug Development

  HUYA Bioscience International Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound

  March 3, 2008

   · 

  4 min read
• Business

  Emergent BioSolutions Appoints Dr. W. James Jackson as Chief Scientific Officer

  March 3, 2008

   · 

  1 min read
• Business

  AEterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008

  March 3, 2008

   · 

  1 min read
• BioMidwest

  Celerus Diagnostics Launches Rapid Diagnostic Tool

  March 3, 2008

   · 

  1 min read
• Phase Forward Introduces Empirica(TM) Trace - Significant New Release of Adverse Event Management Product

  March 3, 2008

   · 

  1 min read
• Business

  OneWorld Health, Amyris Biotechnologies, Inc. and Sanofi-Aventis (France) Announce Development Agreement for Semisynthetic Artemisinin

  March 3, 2008

   · 

  1 min read